Stay updated on Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial
Sign up to get notified when there's something new on the Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial page.

Latest updates to the Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial page
- CheckyesterdayChange DetectedA notice was added about the NIH website transition, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.SummaryDifference0.5%

- Check8 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check15 days agoChange DetectedThe footer revision label was updated from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision tag, Revision: v3.7.0, appears in the history, replacing the prior Revision: v3.6.6. This indicates the study record on ClinicalTrials.gov was updated to a newer version.SummaryDifference0.1%

- Check57 days agoChange DetectedA new version entry, Revision: v3.6.6, was added to the history, replacing Revision: v3.6.5 and signaling a software/UI update to the page history.SummaryDifference0.1%

- Check78 days agoChange DetectedThe history now shows Revision: v3.6.5, replacing the previous v3.6.4 entry. This indicates a new page revision has been recorded in the study record history on ClinicalTrials.gov.SummaryDifference0.1%

Stay in the know with updates to Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial page.